Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients

Medical Mycology

Volumn 48, Issue 1, 2010, Pages 141-146

  Kalkanci, Ayse ^a,b   Sugita, Takashi ^b   Arikan, Sevtap ^c   Yucesoy, Mine ^d   Ener, Beyza ^e   Otag, Feza ^f   Kiraz, Nuri ^g   Kustimur, Semra ^a   Sancak, Banu ^c   Evci, Canan ^e   Emektas, Gurol ^f  

^a GAZI UNIVERSITY   (Turkey)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c HACETTEPE UNIVERSITY   (Turkey)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e ULUDAG UNIVERSITY   (Turkey)

^f MERSIN UNIVERSITY   (Turkey)

^g ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Drug susceptibility; Genotype; Trichosporon asahii; Turkey

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; RIBOSOME DNA; SPACER DNA; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ARTICLE; BASIDIOMYCETES; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; FUNGAL STRAIN; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; TRICHOSPORON; TRICHOSPORON ASAHII; TRICHOSPORON ASTEROIDS; TRICHOSPORON COREMIIFORME; TRICHOSPORON FAECALE; TRICHOSPORON JAPONICUM; TRICHOSPORON LACTIS; TURKEY (REPUBLIC); YEAST; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY; TURKEY;

TRICHOSPORON ASAHII; TRICHOSPORON COREMIIFORME; TRICHOSPORON FAECALE; TRICHOSPORON JAPONICUM; TRICHOSPORON LACTIS;

ANTIFUNGAL AGENTS; CLUSTER ANALYSIS; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TRICHOSPORON; TURKEY;

EID: 74949131584     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780902977984     Document Type: Article

References (33)

1. Erer B, Galimberti M, Lucarelli G, et al. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant 2000; 25: 745-749.
2. Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16: 915-933.
3. Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 1: 48-66.
4. Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43: 1818-1828.
5. Matsue K, Uryu H, Koseki M, et al. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006; 15: 753-757.
6. Bayramoglu G, Sonmez M, Tosun I, et al. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 2008; 36: 68-70.
7. Toriumi Y, Sugita T, Nakajima M, et al. Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology. Microbiol Immunol 2002; 46: 89-93.
8. Wolf DG, Falk R, Hacham M, et al. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39: 4420-4425.
9. Falk R, Wolf DG, Shapiro M, et al. Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 2003; 41: 911.
10. Gueho E, Improvisi L, De Hoog et al. Trichosporon on humans: a practical account. Mycoses 1994; 37: 3-10.
11. Kustimur S, Kalkanci A, Caglar K, et al. Nosocomial fungemia due to Trichosporon asteroides: firstly described bloodstream infection. Diagn Microbiol Infect Dis 2002; 43: 167-170.
12. Padhye AA, Verghese S, Ravichandran P, et al. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol 2003; 41: 479-482.
13. Kendirli T, Ciftci E, Ince E, et al. Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine. Mycoses 2006; 49: 251-253.
14. A(irbasli H, Bilgen H, Ozcan SK, et al. Two possible cases of Trichosporon infections in bone-marrow-transplanted children: the first case of T. japonicum isolated from clinical specimens. Jpn J Infect Dis 2008; 61: 130-132.
15. Sugita T, Nakajima M, Ikeda R, et al. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40: 1826-1830.
16. Makimura K, Murayama SY, Yamaguchi H. Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 1994; 40: 358-364.
17. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680.
18. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
19. Kimura M. A simple method for estimation of evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-120.
20. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39: 783-791.
21. Kalkanci A, Mehka N, Poonwan N, et al. Comparative evaluation of Trichosporon asahii susceptibility using the ASTY colorimetric microdilution method and the CLSI M27-A2 broth microdilution reference method. Microbiol Immunol 2008; 52: 435-439.
22. Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-1223.
23. Sugita T, Nishikawa A. Molecular taxonomy and identification of pathogenic fungi based on DNA sequence analysis. Nippon Ishinkin Gakkai Zasshi 2004; 45: 55-58.
24. Sugita T, Nishikawa A, Ikeda R, et al. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J Clin Microbiol 1999; 37: 1985-1993.
25. Sugita T, Ikeda R, Shinoda T. Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide. Microbiol Immunol 2001; 45: 757-768.
26. Sugita T, Takeo K, Hama K, et al. DNA sequence diversity of intergenic spacer I region in the non-lipid-dependent species Malassezia pachydermatis isolated from animals. Med Mycol 2005; 43: 21-26.
27. Sutar R, David JK, Ganesan K, et al. Comparison of ITS and IGS1 regions for strain typing of clinical and non-clinical isolates of Pichia anomala. J Med Microbiol 2004; 53: 119-123.
28. Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, et al. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 2007; 58: 435-440.
29. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026-4034.
30. Bhardwaj S, Sutar R, Bachhawat AK, et al. PCR-based identification and strain typing of Pichia anomala using the ribosomal intergenic spacer region IGS1. J Med Microbiol 2007; 56: 185-189.
31. Hahner D, Kirschner R, Piepenbring M, et al. First isolation of the anamorphic basidiomycetous yeast Trichosporon faecale in Germany, from the skin of a patient with tinea pedis. Mycopathologia. 2008; 165: 149-153.
32. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, et al. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144-1146.
33. Li HM, Du HT, Liu W, et al. Microbiological characteristics of medically important Trichosporon species. Mycopathologia. 2005; 160: 217-225.